Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer’s disease in mild cognitive impairment patients

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

(2016) Ronald C. Petersen et al.   JAMA Neurology

The feasibility of11C-PIB-PET/CT for amyloid plaque burden: validation of the effectiveness of CT-based partial volume correction

(2016) Kei Sasaki et al.   Brain and Behavior

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

(2015) Sylvia Villeneuve et al.   BRAIN

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mild cognitive impairment: a concept in evolution

(2014) R. C. Petersen et al.   JOURNAL OF INTERNAL MEDICINE

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Brain  -amyloid load approaches a plateau

(2013) C. R. Jack et al.   NEUROLOGY

18F-florbetaben Aβ imaging in mild cognitive impairment

(2013) Kevin Ong et al.   Alzheimers Research & Therapy

Why we need two cutoffs for amyloid imaging: Early versus Alzheimer's-like amyloid-positivity

(2012) William Klunk et al.   Alzheimers & Dementia

Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population

(2012) Marco Monaco et al.   NEUROLOGICAL SCIENCES

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

(2011) Adam S. Fleisher   ARCHIVES OF NEUROLOGY

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test

(2011) Ana Pozueta et al.   BMC Neurology

Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias

(2011) V. L. Villemagne et al.   JOURNAL OF NUCLEAR MEDICINE

Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant

(2011) Elizabeth C. Mormino et al.   NEUROIMAGE

Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study

(2011) J. Koivunen et al.   NEUROLOGY

Early Diagnosis of Alzheimers Disease: Is MCI Too Late?

(2009) Ronald Petersen   Current Alzheimer Research

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study

(2009) A. Okello et al.   NEUROLOGY

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

(2008) Clifford R. Jack et al.   BRAIN

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

(2008) Christopher C Rowe et al.   LANCET NEUROLOGY